U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2023
446
Substance Class Nucleic Acid
Created
by admin
on Wed Apr 02 17:37:54 GMT 2025
Edited
by admin
on Wed Apr 02 17:37:54 GMT 2025
Nucleic Acid Type mRNA VACCINE
Sequence Origin VIRAL
Sequence Type COMPLETE
Record UNII
4F9QRS7ZV2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CX-038839 Omicron (XBB.1.5)
Preferred Name English
Andusomeran
INN  
Official Name English
CX-038839 (COVID-19 Omicron subvariant Kraken) prefusion spike protein mRNA
Common Name English
CX-038839
Code English
Andusomeran [WHO-DD]
Common Name English
CX-038839 (COVID-19 Omicron subvariant XBB.1.5) prefusion spike protein mRNA
Common Name English
andusomeran [INN]
Common Name English
RNA (recombinant 5?-(m7G-(5??5?)-ppp-Gm)-capped all uridine?N1-methylpseudouridine-substituted severe acute respiratory syndrome coronavirus 2 pre-fusion spike glycoprotein [982-proline,983-proline] XBB.1.5 variant plus 5?- and 3?-untranslated flanking r
Common Name English
messenger RNA (mRNA), 5'-capped, encoding a full-length, codon-optimised pre-fusion stabilised conformation variant (K982P and V983P) of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) spike (S) glycoprotein (Omicron variant XBB.1.5; bas
Common Name English
Code System Code Type Description
CAS
2918977-08-7
Created by admin on Wed Apr 02 17:37:54 GMT 2025 , Edited by admin on Wed Apr 02 17:37:54 GMT 2025
PRIMARY
INN
13097
Created by admin on Wed Apr 02 17:37:54 GMT 2025 , Edited by admin on Wed Apr 02 17:37:54 GMT 2025
PRIMARY
SMS_ID
300000051178
Created by admin on Wed Apr 02 17:37:54 GMT 2025 , Edited by admin on Wed Apr 02 17:37:54 GMT 2025
PRIMARY
NCI_THESAURUS
C203097
Created by admin on Wed Apr 02 17:37:54 GMT 2025 , Edited by admin on Wed Apr 02 17:37:54 GMT 2025
PRIMARY
FDA UNII
4F9QRS7ZV2
Created by admin on Wed Apr 02 17:37:54 GMT 2025 , Edited by admin on Wed Apr 02 17:37:54 GMT 2025
PRIMARY
Sugar Site Range Site Count
D-Ribose (RNA) 1_1-1_4101 4101 / 4101
Linkage Site Range Site Count
Phosphate 1_2-1_4101 4100 / 4100
Related Record Type Details
SARS-COV2
TARGET ORGANISM->VACCINE ANTIGEN
Related Record Type Details
Andusomeran
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
NUCLEOSIDE_SUBSTITUTION U N1-METHYLPSEUDOURIDINE 09RAD4M6WF
NUCLEOTIDE SUBSTITUTION [1_1] 5'-GUANOSINE-M-RNA-CAP-1-3'-PHOSPHATE T0HQY09X7B
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966